Researchers at the University of Tokyo and collaborators have developed a bioinspired sensor that monitors the heartbeat of lab-grown cardiac tissue. The device mimics the lateral line system found in fish, which detects water movement and pressure changes.
The team engineered a biomechanical well plate, a small white box containing four liquid-filled chambers. Each well holds three-dimensional heart tissue grown in the laboratory, known as cardiac organoids. The sensor detects subtle mechanical contractions produced by the beating tissue without direct contact, similar to how fish sense movement through water.
This technology addresses a longstanding challenge in cardiac tissue engineering. Researchers need reliable methods to assess whether lab-grown heart cells function properly and respond to drugs. Traditional measurement techniques often require invasive electrodes or cameras, which can damage delicate tissue or provide incomplete data.
The lateral line inspiration proves elegant for this application. Fish use this organ system to perceive vibrations and pressure waves at distances. The sensor translates this principle into detecting the nanometer-scale movements of contracting cardiac tissue within liquid wells. The device allows researchers to monitor multiple tissue samples simultaneously, improving experimental throughput.
Cardiac organoids represent a frontier in regenerative medicine and drug testing. They model aspects of heart disease and offer potential alternatives to animal testing. Accurate, non-invasive monitoring accelerates research by providing real-time feedback on tissue health and responsiveness.
The biomechanical well plate measures changes in liquid dynamics caused by tissue contractions, offering insights into cardiac function that electrical recordings alone cannot provide. This mechanical perspective complements existing electrophysiological data.
The innovation has immediate applications in pharmaceutical development, where companies screen compounds for cardiac toxicity. Researchers can now evaluate drug effects on three-dimensional tissue that more closely resembles the heart's actual structure than traditional two-dimensional cell cultures.
Further development could extend this sensing technology to other organ